Multilab

Porto Alegre, Brazil Founded: 1988 • Age: 38 yrs Acquired By Takeda
Information on gift card cashing options and methods is provided.

About Multilab

Multilab is a Healthcare company based in Porto Alegre (Brazil) founded in 1988, and was acquired by Takeda in May 2012. Information on gift card cashing options and methods is provided. It operates on a Direct-to-Consumer (D2C) and Reseller / Distribution model. Multilab offers products and services including ResfeGripe, Buprovil, Multipiral, and Nexoprax. Its focus areas include Pharmaceuticals and Generic Drugs. Its legal entity is Multilab Indústria e Comércio de Produtos Farmacêuticos Ltda.

Company details

Multilab, a Brazilian company, is involved in the research, development, production, and distribution of pharmaceutical products across various therapeutic areas. It operates within the healthcare sector, offering a wide portfolio of medications, including prescription and over-the-counter drugs. As part of Grupo NC, one of the largest pharmaceutical groups in Latin America, Multilab focuses on providing accessible medicinal solutions through a presence in over 87,000 points of sale. Its offerings address diverse health needs with a commitment to quality and trust.

  • Headquarters Porto Alegre, Brazil
  • Stage Acquired
  • Sectors
    Healthcare
  • Phone
    •••• ••••
  • Website multilab.com.br
  • Social X Facebook Instagram
  • Acquired by Takeda (May 2012)
  • Legal Name Multilab Indústria E Comércio De Produtos Farmacêuticos Ltda
Key Metrics

Products & Services of Multilab

Multilab offers a comprehensive portfolio of products and services, including ResfeGripe, Buprovil, Multipiral, and Nexoprax.

ResfeGripe
Pharmaceuticals

Used for treating symptoms of colds and flu.

Buprovil
Pharmaceuticals

Provides anti-inflammatory, analgesic, and antipyretic effects.

Multipiral
Pharmaceuticals

Indicated as analgesic and antipyretic for pain relief.

Nexoprax
Pharmaceuticals

Used for acute pain and inflammation relief.

Investors in Multilab

Multilab has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Takeda Pharmaceuticals.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Takeda Pharmaceuticals is engaged in developing innovative medicines globally.
1781takeda.comTokyo, Japan
Premium access

Investor details for Multilab

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Multilab

2 dated milestones of Multilab across 24 years, from founding to its latest funding, stage changes and deals.

  1. Founded Multilab is founded.
  2. Exit Acquired by Takeda.

Web traffic of Multilab

The website of Multilab (multilab.com.br) receives about 9.3K visits a month.

  • Monthly visits
    9.3K

    ▲ 16.5% vs previous month

Similar websites

Websites whose visitors overlap most with Multilab. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
farmagora.com.br
100%
#6,234,052View details
mevofarma.com.br
85%
138K#337,329View details
farmaciamix.com.br
farmaciamix.com.br
82%
#4,980,808–
drogarianovaesperanca.com.br
drogarianovaesperanca.com.br
41%
#72,448–
araujo.com.br
araujo.com.br
41%
#17,302–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 6 similar websites and full traffic analytics for Multilab

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 6 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Multilab

Multilab was founded in 1988.

Multilab is headquartered in Porto Alegre, Brazil. It is registered at Porto Alegre, Rio Grande Do Sul, Brazil.

Multilab, a Brazilian company, is involved in the research, development, production, and distribution of pharmaceutical products across various therapeutic areas. It operates within the healthcare sector, offering a wide portfolio of medications, including prescription and over-the-counter drugs. As part of Grupo NC, one of the largest pharmaceutical groups in Latin America, Multilab focuses on providing accessible medicinal solutions through a presence in over 87,000 points of sale. Its offerings address diverse health needs with a commitment to quality and trust.

Multilab offers ResfeGripe, Buprovil, Multipiral, and Nexoprax.

Multilab has 1 investor. Key investors include Takeda Pharmaceuticals.

Multilab operates through Multilab Indústria E Comércio De Produtos Farmacêuticos Ltda.

Yes. Multilab was acquired by Takeda in May 2012.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available